Financial Contrast: Jushi (JUSHF) vs. Its Competitors

Jushi (OTCMKTS:JUSHF) is one of 55 publicly-traded companies in the “Medicinals & botanicals” industry, but how does it compare to its peers? We will compare Jushi to similar companies based on the strength of its analyst recommendations, dividends, valuation, institutional ownership, earnings, profitability and risk.

Insider & Institutional Ownership

21.7% of Jushi shares are held by institutional investors. Comparatively, 16.1% of shares of all “Medicinals & botanicals” companies are held by institutional investors. 21.0% of Jushi shares are held by insiders. Comparatively, 22.4% of shares of all “Medicinals & botanicals” companies are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Profitability

This table compares Jushi and its peers’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Jushi	-24.16%	-320.66%	-10.31%
Jushi Competitors	-45.53%	-60.43%	-9.08%

Analyst Ratings

This is a summary of recent recommendations for Jushi and its peers, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Jushi	0	2	0	0	2.00
Jushi Competitors	246	546	920	66	2.45

As a group, “Medicinals & botanicals” companies have a potential upside of 74.79%. Given Jushi’s peers stronger consensus rating and higher possible upside, analysts clearly believe Jushi has less favorable growth aspects than its peers.

Risk and Volatility

Jushi has a beta of -0.16, suggesting that its share price is 116% less volatile than the S&P 500. Comparatively, Jushi’s peers have a beta of 1.36, suggesting that their average share price is 36% more volatile than the S&P 500.

Earnings & Valuation

This table compares Jushi and its peers top-line revenue, earnings per share and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
Jushi	$269.45 million	-$65.10 million	-2.03
Jushi Competitors	$309.02 million	-$154.30 million	-10.35

Jushi’s peers have higher revenue, but lower earnings than Jushi. Jushi is trading at a higher price-to-earnings ratio than its peers, indicating that it is currently more expensive than other companies in its industry.

Summary

Jushi peers beat Jushi on 9 of the 13 factors compared.

Jushi Company Profile

Jushi Holdings Inc., a vertically integrated cannabis company, engages in the cultivation, processing, retail, and distribution of medical and adult-use products. It focuses on building a portfolio of cannabis assets in various jurisdictions in Pennsylvania, Virginia, Ohio, Illinois, California, Nevada, and Massachusetts. The company also offers hemp-based CBD products, including cannabis dry flower, vaporizer forms of cannabis, edibles, cannabis oil in capsules, tinctures, cannabis in topical products, and other cannabis products, as well as vape cartridges, disposables, and concentrates under The Bank, The Lab, Nira+ Medicinals, Sèchè, Tasteology, and Hijinks brands. In addition, it operates medical cannabis dispensaries under the BEYOND/HELLO, Nature's Remedy, and NuLeaf brands. The company is headquartered in Boca Raton, Florida.